Park Seul Ki, Min Yul Ha
Department of Nursing, Daejeon University, Daejeon, Republic of Korea.
College of Nursing, Kangwon National University, Kangwon-do, Republic of Korea.
Front Psychol. 2023 Jul 27;14:1170077. doi: 10.3389/fpsyg.2023.1170077. eCollection 2023.
Fear of cancer recurrence (FCR) is one of the most-prevalent psychological problems among cancer survivors, and younger females who have received endocrine therapy are particularly at risk of high FCR. The aim of this study was to determine the relationship between high FCR and factors related to it in South Korean patients with breast cancer who receive adjuvant endocrine therapy (AET).
This cross-sectional study recruited 326 patients with breast cancer who had received AET. All participants were asked to complete a personal information sheet, the short form of the Fear of Progression Questionnaire, and the Menopause Rating Scale. The factors associated with high FCR were analyzed using association-rule analysis.
The mean FCR score was 32.24 (SD = 10.22), and 137 of the 326 (42.0%) patients had high scores (≥34). Hot flushes and sweating (moderate to extremely severe), depressed mood (moderate to extremely severe), irritability (moderate to extremely severe), invasive stage, taking tamoxifen, and being married were associated with high FCR.
Since FCR was common in patients with breast cancer who received AET, patients at a greater risk of experiencing FCR must be screened and supported.
对癌症复发的恐惧（FCR）是癌症幸存者中最普遍的心理问题之一，接受内分泌治疗的年轻女性尤其容易出现高FCR。本研究的目的是确定接受辅助内分泌治疗（AET）的韩国乳腺癌患者中高FCR与其相关因素之间的关系。
这项横断面研究招募了326例接受AET的乳腺癌患者。所有参与者均被要求填写一份个人信息表、《疾病进展恐惧问卷简表》和《更年期评定量表》。使用关联规则分析与高FCR相关的因素。
FCR平均得分为32.24（标准差=10.22），326例患者中有137例（42.0%）得分较高（≥34）。潮热和出汗（中度至极度严重）、情绪低落（中度至极度严重）、易怒（中度至极度严重）、浸润期、服用他莫昔芬和已婚与高FCR相关。
由于FCR在接受AET的乳腺癌患者中很常见，因此必须对有更高FCR风险的患者进行筛查和支持。
